On the other hand, the vaccine reached the tumor site, releasing Zn2+ in acidic tumor microenvironment, improving the activity of MMP‐2, promoting ECM collagen degradation, and enhancing tumor invasion and killing of CD8+ T cells (Figure 1b). Here, CD8A is linked to neoplasm.